230 related articles for article (PubMed ID: 21272775)
1. The post-BART anti-fibrinolytic dilemma?
Beattie WS; Karkouti K
J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):3-5. PubMed ID: 21272775
[No Abstract] [Full Text] [Related]
2. ε-Aminocaproic acid and clinical value in cardiac anesthesia.
Raghunathan K; Connelly NR; Kanter GJ
J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):16-9. PubMed ID: 20870423
[TBL] [Abstract][Full Text] [Related]
3. Antifibrinolytics.
Schmarts
Acta Anaesthesiol Belg; 2003; 54(4):319-22. PubMed ID: 14719353
[No Abstract] [Full Text] [Related]
4. Antifibrinolytics in liver transplantation.
Groenland TH; Porte RJ
Int Anesthesiol Clin; 2006; 44(3):83-97. PubMed ID: 16832208
[No Abstract] [Full Text] [Related]
5. eComment: A comparison of the safety of aprotinin and tranexamic acid in cardiac surgery.
Koniari I; Apostolakis E; Mandellou M
Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):101. PubMed ID: 19546299
[No Abstract] [Full Text] [Related]
6. Current status of non-transfusional haemostatic agents.
Cattaneo M; Mannucci PM
Haematologica; 1999 Jun; 84 Suppl EHA-4():120-3. PubMed ID: 10907488
[No Abstract] [Full Text] [Related]
7. Aprotinin increases mortality as compared with tranexamic acid in cardiac surgery: a meta-analysis of randomized head-to-head trials.
Takagi H; Manabe H; Kawai N; Goto SN; Umemoto T
Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):98-101. PubMed ID: 19380335
[TBL] [Abstract][Full Text] [Related]
8. Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era.
Koster A; Schirmer U
Curr Opin Anaesthesiol; 2011 Feb; 24(1):92-7. PubMed ID: 20881484
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic drugs.
Mannucci PM
N Engl J Med; 1998 Jul; 339(4):245-53. PubMed ID: 9673304
[No Abstract] [Full Text] [Related]
10. Seizures after open heart surgery: comparison of ε-aminocaproic acid and tranexamic acid.
Martin K; Knorr J; Breuer T; Gertler R; Macguill M; Lange R; Tassani P; Wiesner G
J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):20-5. PubMed ID: 21272777
[TBL] [Abstract][Full Text] [Related]
11. Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
Body SC; Mazer CD
Anesth Analg; 2006 Dec; 103(6):1354-9. PubMed ID: 17122202
[No Abstract] [Full Text] [Related]
12. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery.
Karkouti K; Wijeysundera DN; Yau TM; McCluskey SA; Tait G; Beattie WS
Anesth Analg; 2010 Jan; 110(1):21-9. PubMed ID: 19910626
[TBL] [Abstract][Full Text] [Related]
13. The risk associated with aprotinin in cardiac surgery.
Mangano DT; Tudor IC; Dietzel C; ;
N Engl J Med; 2006 Jan; 354(4):353-65. PubMed ID: 16436767
[TBL] [Abstract][Full Text] [Related]
14. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Fergusson DA; Hébert PC; Mazer CD; Fremes S; MacAdams C; Murkin JM; Teoh K; Duke PC; Arellano R; Blajchman MA; Bussières JS; Côté D; Karski J; Martineau R; Robblee JA; Rodger M; Wells G; Clinch J; Pretorius R;
N Engl J Med; 2008 May; 358(22):2319-31. PubMed ID: 18480196
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
Levi M; Cromheecke ME; de Jonge E; Prins MH; de Mol BJ; Briët E; Büller HR
Lancet; 1999 Dec; 354(9194):1940-7. PubMed ID: 10622296
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
[TBL] [Abstract][Full Text] [Related]
17. Lessons learned in antifibrinolytic therapy: The BART trial.
Murkin JM
Semin Cardiothorac Vasc Anesth; 2009 Jun; 13(2):127-31. PubMed ID: 19622534
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery.
Brown JR; Birkmeyer NJ; O'Connor GT
Circulation; 2007 Jun; 115(22):2801-13. PubMed ID: 17533182
[TBL] [Abstract][Full Text] [Related]
19. Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials.
Carless PA; Moxey AJ; Stokes BJ; Henry DA
BMC Cardiovasc Disord; 2005 Jul; 5():19. PubMed ID: 15992412
[TBL] [Abstract][Full Text] [Related]
20. Blood-sparing drugs: aprotinin, tranexamic acid, and epsilon-aminocaproic acid.
Royston D
Int Anesthesiol Clin; 1995; 33(1):155-79. PubMed ID: 7543455
[No Abstract] [Full Text] [Related]
[Next] [New Search]